User profiles for Anthony C. Fries
 | Anthony C FriesAir Force Research Laboratory Verified email at us.af.mil Cited by 1005 |
SARS-CoV-2 BA. 1 variant is neutralized by vaccine booster–elicited serum but evades most convalescent serum and therapeutic antibodies
The rapid spread of the highly contagious Omicron variant of severe acute respiratory syndrome
coronavirus 2 (SARS-CoV-2) along with its high number of mutations in the spike gene …
coronavirus 2 (SARS-CoV-2) along with its high number of mutations in the spike gene …
[PDF][PDF] Antigenic cartography of well-characterized human sera shows SARS-CoV-2 neutralization differences based on infection and vaccination history
The rapid emergence of SARS-CoV-2 variants challenges vaccination strategies. Here, we
collected 201 serum samples from persons with a single infection or multiple vaccine …
collected 201 serum samples from persons with a single infection or multiple vaccine …
assignPOP: An r package for population assignment using genetic, non‐genetic, or integrated data in a machine‐learning framework
The use of biomarkers (eg, genetic, microchemical and morphometric characteristics) to
discriminate among and assign individuals to a population can benefit species conservation and …
discriminate among and assign individuals to a population can benefit species conservation and …
[HTML][HTML] SARS-CoV-2 Omicron neutralization by therapeutic antibodies, convalescent sera, and post-mRNA vaccine booster
The rapid spread of the highly contagious Omicron variant of SARS-CoV-2 along with its high
number of mutations in the spike gene has raised alarm about the effectiveness of current …
number of mutations in the spike gene has raised alarm about the effectiveness of current …
[PDF][PDF] The SARS-CoV-2 mRNA vaccine breakthrough infection phenotype includes significant symptoms, live virus shedding, and viral genetic diversity
Little is known about SARS-CoV-2 ‘vaccine-breakthrough’infections (VBI). Here we characterize
24 VBI in predominantly young healthy persons. While none required hospitalization, a …
24 VBI in predominantly young healthy persons. While none required hospitalization, a …
[HTML][HTML] Understanding'hybrid immunity': comparison and predictors of humoral immune responses to SARS-CoV-2 infection and COVID-19 vaccines.
…, A Ganesan, N Huprikar, T Lalani, AC Fries… - Clin. infect …, 2022 - pesquisa.bvsalud.org
BACKGROUND: Comparing humoral responses in SARS-CoV-2 vaccinees, those with
SARS-CoV-2 infection, or combinations of vaccine/infection ('hybrid immunity'), may clarify …
SARS-CoV-2 infection, or combinations of vaccine/infection ('hybrid immunity'), may clarify …
Variants in SARS-CoV-2 associated with mild or severe outcome
Introduction The coronavirus disease 2019 (COVID-19) pandemic is a global public health
emergency causing a disparate burden of death and disability around the world. The viral …
emergency causing a disparate burden of death and disability around the world. The viral …
Persistent COVID-19 symptoms at 6 months after onset and the role of vaccination before or after SARS-CoV-2 infection
SA Richard, SD Pollett, AC Fries, CM Berjohn… - JAMA network …, 2023 - jamanetwork.com
Importance Understanding the factors associated with post-COVID conditions is important
for prevention. Objective To identify characteristics associated with persistent post–COVID-19 …
for prevention. Objective To identify characteristics associated with persistent post–COVID-19 …
COVID-19 outcomes among US Military Health System beneficiaries include complications across multiple organ systems and substantial functional impairment
…, CA Lanteri, EV Millar, AC Fries… - Open Forum …, 2021 - academic.oup.com
Background We evaluated clinical outcomes, functional burden, and complications 1 month
after coronavirus disease 2019 (COVID-19) infection in a prospective US Military Health …
after coronavirus disease 2019 (COVID-19) infection in a prospective US Military Health …
Understanding “hybrid immunity”: comparison and predictors of humoral immune responses to severe acute respiratory syndrome coronavirus 2 infection (SARS-CoV …
…, N Huprikar, T Lalani, AC Fries… - Clinical Infectious …, 2023 - academic.oup.com
Background Comparison of humoral responses in severe acute respiratory syndrome
coronavirus 2 (SARS-CoV-2) vaccinees, those with SARS-CoV-2 infection, or combinations of …
coronavirus 2 (SARS-CoV-2) vaccinees, those with SARS-CoV-2 infection, or combinations of …
